https://www.selleckchem.com/pr....oducts/pembrolizumab
At right heart catheterization performed after 1 year of follow-up, cardiac index and pulmonary vascular resistance remained stable, while a decrease in systolic pulmonary artery pressure and pulmonary capillary wedge pressure is observed. Furosemide dosage decrease from 102.7 ± 69.4 to 78.7 ± 66.3 mg (P = 0.04. PF decreased from 3.35 ± 1.0 at baseline to 1.57 ± 1.3 at the end of follow-up (P less then 0.001), with a reduction in all PF domains. CONCLUSIONS Our study showed a rapid improvement in PF in HT waiting list patients t
Like
Comment
Share
